Surgery for Esophageal Cancer. Goals of Resection and Optimizing Outcomes.

Thoracic Surgery Clinics

Volumn 23, Issue 4, 2013, Pages 491-498

  Rizk, Nabil ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Distal margins; Esophageal cancer; Lymphadenectomy; Proximal margins; Radial margins

Indexed keywords

CANCER SURGERY; CANCER THERAPY; CHEMORADIOTHERAPY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; ESOPHAGUS SURGERY; FROZEN SECTION; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; METAPLASIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; STOMACH TUMOR; SURGICAL APPROACH; SURGICAL RISK; TREATMENT OUTCOME;

DISTAL MARGINS; ESOPHAGEAL CANCER; LYMPHADENECTOMY; PROXIMAL MARGINS; RADIAL MARGINS;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 84887104757     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2013.07.009     Document Type: Review

References (43)

1. Veeramachaneni N.K., Zoole J.B., Decker P.A., American College of Surgeons Oncology Group Z0060 Trial, et al. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial. Ann Thorac Surg 2008, 86(2):418-421. [discussion: 421].
2. Rizk N.P., Ishwaran H., Rice T.W., et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg 2010, 251(1):46-50.
3. Ancona E., Rampado S., Cassaro M., et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008, 15(11):3278-3288.
4. Bollschweiler E., Baldus S.E., Schröder W., et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006, 38(2):149-156.
5. Lerut T., Nafteux P., Moons J., et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004, 240(6):962-972. [discussion: 972-4].
6. Altorki N., Kent M., Ferrara C., et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002, 236(2):177-183.
7. Stein H.J., Feith M., Bruecher B.L., et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005, 242(4):566-573. [discussion: 573-5].
8. AJCC cancer staging Manual 2010, Springer. 7th edition. S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
9. Feith M., Stein H.J., Siewert J.R. Pattern of lymphatic spread of Barrett's cancer. World J Surg 2003, 27(9):1052-1057.
10. Chen J., Liu S., Pan J., et al. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg 2009, 36(3):480-486.
11. Schröder W., Mönig S.P., Baldus S.E., et al. Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol 2002, 9(8):807-811.
12. Fox M.P., van Berkel V. Management of gastroesophageal junction tumors. Surg Clin North Am 2012, 92(5):1199-1212.
13. Rüdiger Siewert J., Feith M., Werner M., et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000, 232(3):353-361.
14. Nishihira T., Hirayama K., Mori S. Aprospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 1998, 175(1):47-51.
15. Hosch S.B., Stoecklein N.H., Pichlmeier U., et al. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. JClin Oncol 2001, 19(7):1970-1975.
16. Igaki H., Tachimori Y., Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 2004, 239(4):483-490.
17. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. NEngl J Med 2002, 347(21):1662-1669.
18. Cense H.A., van Eijck C.H., Tilanus H.W. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol 2006, 20(5):893-906.
19. Bonenkamp J.J., Songun I., Hermans J., et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995, 345:745-748.
20. Hulscher J.B., Tijssen J.G., Obertop H., et al. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg 2001, 72(1):306-313.
21. Omloo J.M., Lagarde S.M., Hulscher J.B., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007, 246(6):992-1000. [discussion: 1000-1].
22. Schwarz R.E., Smith D.D. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. JGastrointest Surg 2007, 11(11):1384-1393. [discussion: 1393-4].
23. Rizk N.P., Venkatraman E., Park B., et al. The prognostic importance of the number of involved nodes in esophageal cancer: implications for revisions ofthe American Joint Committee on Cancer Staging System. JThorac Cardiovasc Surg 2006, 132:1374-1381.
24. Peyre C.G., Hagen J.A., DeMeester S.R., et al. The number of lymph nodes removed predicts survival in esophageal cancer: an International Study on the Impact of Extent of Surgical Resection. Ann Surg 2008, 248:190-197.
25. Deeter M., Dorer R., Kuppusamy M.K., et al. Assessment of criteria and clinical significance of circumferential resection margins in esophageal cancer. Arch Surg 2009, 144(7):618-624.
26. Verhage R.J., Zandvoort H.J., ten Kate F.J., et al. How to define a positive circumferential resection margin in T3 adenocarcinoma of the esophagus. Am J Surg Pathol 2011, 35(6):919-926.
27. Dexter S.P., Sue-Ling H., McMahon M.J., et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001, 48(5):667-670.
28. Pultrum B.B., Honing J., Smit J.K., et al. Acritical appraisal of circumferential resection margins in esophageal carcinoma. Ann Surg Oncol 2010, 17(3):812-820.
29. Rao V.S., Yeung M.M., Cooke J., et al. Comparison of circumferential resection margin clearance criteria with survival after surgery for cancer of esophagus. JSurg Oncol 2012, 105(8):745-749.
30. Khan O.A., Fitzgerald J.J., Soomro I., et al. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br J Cancer 2003, 88(10):1549-1552.
31. Suttie S.A., Nanthakumaran S., Mofidi R., et al. The impact of operative approach for oesophageal cancer on outcome: the transhiatal approach may influence circumferential margin involvement. Eur J Surg Oncol 2012, 38(2):157-165.
32. Williams V.A., Peters J.H. Adenocarcinoma of the gastroesophageal junction: benefits of an extended lymphadenectomy. Surg Oncol Clin N Am 2006, 15(4):765-780.
33. van Hagen P., Hulshof M.C., van Lanschot J.J., et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. NEngl J Med 2012, 366:2074-2084.
34. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. NEngl J Med 1998, 339:1979-1984.
35. Kim K.T., Jeong O., Jung M.R., et al. Outcomes of abdominal total gastrectomy for Type II and II gastroesophageal junction tumors: single center's experience in Korea. JGastric Cancer 2012, 12(1):36-42.
36. Papachristou D.N., Agnanti N., D'Agostino H., et al. Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg 1980, 139(5):711-713.
37. Johansson J., Djerf P., Oberg S., et al. Two different surgical approaches in the treatment of adenocarcinoma at the gastroesophageal junction. World J Surg 2008, 32(6):1013-1020.
38. Avella D., Garcia L., Hartman B., et al. Esophageal extension encountered during transhiatal resection of gastric or gastroesophageal tumors: attaining a negative margin. JGastrointest Surg 2009, 13(2):368-373.
39. Mattioli S., Di Simone M.P., Ferruzzi L., et al. Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus 2001, 14(2):104-109.
40. Ito H., Clancy T.E., Osteen R.T., et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?. JAm Coll Surg 2004, 199(6):880-886.
41. Lam K.Y., Ma L.T., Wong J. Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. JClin Pathol 1996, 49(2):124-129.
42. Tsutsui S., Kuwano H., Watanabe M., et al. Resection margin for squamous cell carcinoma of the esophagus. Ann Surg 1995, 222(2):193-202.
43. Kim S.H., Karpeh M.S., Klimstra D.S., et al. Effect of microscopic resection line disease on gastric cancer survival. JGastrointest Surg 1999, 3:24-33.